• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意外发现:在中国非肥胖个体的一项为期5年的纵向队列研究中,基础代谢率是代谢功能障碍相关脂肪性肝病的独立危险因素。

Unanticipated discovery: basal metabolic rate as an independent risk factor for metabolic dysfunction-associated steatotic liver disease in a 5-year longitudinal cohort study of non-obese individuals in China.

作者信息

Luo Jian, Gong Danfeng, Guo Min, Cheng Long, Wu Xueyan

机构信息

Department of Endocrinology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China.

Department of Gastroenterology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China.

出版信息

Front Med (Lausanne). 2025 Sep 1;12:1569655. doi: 10.3389/fmed.2025.1569655. eCollection 2025.

DOI:10.3389/fmed.2025.1569655
PMID:40959437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12434760/
Abstract

OBJECTIVE

The role of basal metabolic rate (BMR) in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) remains controversial, with previous studies yielding inconsistent results. The precise relationship remains poorly understood, particularly in non-obese individuals. This study aimed to investigate the longitudinal association between BMR and incident MASLD in a large, non-obese Chinese cohort.

METHODS

This longitudinal cohort study included 16,173 non-obese participants free of MASLD at baseline. They were prospectively followed up for 5 years, with the outcome event being the development of MASLD. Participants were divided into quartiles based on their basal metabolic rate (BMR). The association between BMR and incident MASLD was examined using both Cox regression models and restricted cubic spline analysis (RCS).

RESULTS

During the 5-year follow-up period, 2,322 non-obese participants developed MASLD. Multivariate Cox regression analysis revealed that after fully adjusting for relevant confounding factors, the BMR was positively associated with incident MASLD, and the risk of MASLD gradually increased with increasing BMR (HR: 1.3, 95% CI: 1.3, 1.4; for trend < 0.0001). Using RCS regression, we found a positive linear correlation between the BMR and the risk of incident MASLD. Stratified analysis revealed an association between the BMR and increased incidence of MASLD in all the subgroups. Additionally, significant interactions were found between BMR and sex, systolic blood pressure (SBP), uric acid (UA), creatinine (CR), and triglycerides (TGs) ( for interaction < 0.05). Mediation analysis indicated that insulin resistance mediated 5.16% of the effect of the BMR on incident MASLD.

CONCLUSION

In this non-obese Chinese cohort, an elevated BMR was identified as an independent risk factor for incident MASLD. This suggests that BMR could be a valuable early biomarker for MASLD risk stratification, even in individuals without obesity.

摘要

目的

基础代谢率(BMR)在代谢功能障碍相关脂肪性肝病(MASLD)中的作用仍存在争议,以往研究结果不一致。其确切关系仍知之甚少,尤其是在非肥胖个体中。本研究旨在调查大型非肥胖中国队列中BMR与新发MASLD之间的纵向关联。

方法

这项纵向队列研究纳入了16173名基线时无MASLD的非肥胖参与者。对他们进行了5年的前瞻性随访,结局事件为MASLD的发生。参与者根据其基础代谢率(BMR)分为四分位数。使用Cox回归模型和限制性立方样条分析(RCS)检查BMR与新发MASLD之间的关联。

结果

在5年随访期内,2322名非肥胖参与者发生了MASLD。多变量Cox回归分析显示,在充分调整相关混杂因素后,BMR与新发MASLD呈正相关,且MASLD风险随BMR升高而逐渐增加(风险比:1.3,95%置信区间:1.3,1.4;趋势P<0.0001)。使用RCS回归,我们发现BMR与新发MASLD风险之间存在正线性相关性。分层分析显示,在所有亚组中BMR与MASLD发病率增加之间均存在关联。此外,还发现BMR与性别、收缩压(SBP)、尿酸(UA)、肌酐(CR)和甘油三酯(TGs)之间存在显著交互作用(交互作用P<0.05)。中介分析表明,胰岛素抵抗介导了BMR对新发MASLD影响的5.16%。

结论

在这个非肥胖中国队列中,较高的BMR被确定为新发MASLD的独立危险因素。这表明,即使在无肥胖个体中,BMR也可能是用于MASLD风险分层的有价值的早期生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/3bb6875c3b40/fmed-12-1569655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/142ee47e65ec/fmed-12-1569655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/92e6b8fa6e9f/fmed-12-1569655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/6ccbb64e63e5/fmed-12-1569655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/3bb6875c3b40/fmed-12-1569655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/142ee47e65ec/fmed-12-1569655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/92e6b8fa6e9f/fmed-12-1569655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/6ccbb64e63e5/fmed-12-1569655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6a/12434760/3bb6875c3b40/fmed-12-1569655-g004.jpg

相似文献

1
Unanticipated discovery: basal metabolic rate as an independent risk factor for metabolic dysfunction-associated steatotic liver disease in a 5-year longitudinal cohort study of non-obese individuals in China.意外发现:在中国非肥胖个体的一项为期5年的纵向队列研究中,基础代谢率是代谢功能障碍相关脂肪性肝病的独立危险因素。
Front Med (Lausanne). 2025 Sep 1;12:1569655. doi: 10.3389/fmed.2025.1569655. eCollection 2025.
2
U-shaped relationship between the triglyceride glucose index and the risk of incident diabetes among MASLD adults: a retrospective cohort study.MAFLD成人中甘油三酯葡萄糖指数与新发糖尿病风险之间的U型关系:一项回顾性队列研究
Front Endocrinol (Lausanne). 2025 Aug 22;16:1516187. doi: 10.3389/fendo.2025.1516187. eCollection 2025.
3
Association of uric acid levels with the development of metabolic dysfunction-associated and metabolic and alcohol-related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups.尿酸水平与代谢功能障碍相关及代谢和酒精相关/伴发的脂肪性肝病发生的关联:一项针对接受健康检查的日本参与者的研究
Endocr J. 2025 Jun 2;72(6):671-687. doi: 10.1507/endocrj.EJ24-0622. Epub 2025 Feb 26.
4
Dietary manganese intake is positively associated with metabolic dysfunction-associated steatotic liver disease: a multicohort study.膳食锰摄入量与代谢功能障碍相关脂肪性肝病呈正相关:一项多队列研究。
Eur J Nutr. 2025 May 26;64(5):188. doi: 10.1007/s00394-025-03708-8.
5
Association between body roundness index and risks of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: NHANES 1999-2018.身体圆润度指数与代谢功能障碍相关脂肪性肝病成人全因死亡率和心血管死亡率风险之间的关联:1999 - 2018年美国国家健康与营养检查调查(NHANES)
Front Nutr. 2025 Jul 8;12:1604398. doi: 10.3389/fnut.2025.1604398. eCollection 2025.
6
Association between metabolic score of visceral fat and all-cause mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a follow-up study based on NHANES III (1988-1994).代谢功能障碍相关脂肪性肝病患者内脏脂肪代谢评分与全因死亡率的关联:基于美国国家健康与营养检查调查III(1988 - 1994年)的随访研究
Diabetol Metab Syndr. 2025 Jul 30;17(1):302. doi: 10.1186/s13098-025-01864-9.
7
Association of predicted basal metabolic rate and insulin resistance in a Chinese general population.中国普通人群中预测基础代谢率与胰岛素抵抗的关联。
BMC Endocr Disord. 2025 Jul 1;25(1):156. doi: 10.1186/s12902-025-01976-3.
8
Association between cumulative uric acid exposure and metabolic dysfunction-associated fatty liver disease.累积尿酸暴露与代谢功能障碍相关脂肪性肝病之间的关联。
BMC Gastroenterol. 2025 Jul 1;25(1):497. doi: 10.1186/s12876-025-04038-z.
9
The serum uric acid to apolipoprotein A1 ratio is independently correlated with metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus: findings from a single national metabolic management center cohort.血清尿酸与载脂蛋白A1比值与2型糖尿病中代谢功能障碍相关脂肪性肝病独立相关:来自单一国家代谢管理中心队列的研究结果
Front Endocrinol (Lausanne). 2025 Jun 4;16:1619003. doi: 10.3389/fendo.2025.1619003. eCollection 2025.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review.瘦素代谢功能障碍相关脂肪性肝病(MASLD)的诊断与管理:一项系统评价
Cureus. 2024 Oct 14;16(10):e71451. doi: 10.7759/cureus.71451. eCollection 2024 Oct.
2
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).《代谢功能障碍相关脂肪性肝病防治指南(2024年版)》
J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4.
3
Metabolic dysfunction associated fatty liver disease in healthy weight individuals.
代谢功能障碍相关的健康体重个体的脂肪肝疾病。
Hepatol Int. 2024 Oct;18(Suppl 2):884-896. doi: 10.1007/s12072-024-10662-w. Epub 2024 Jul 25.
4
Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment.非酒精性脂肪性肝炎:对风险因素、症状及治疗的全面更新综述
Heliyon. 2024 Mar 25;10(7):e28468. doi: 10.1016/j.heliyon.2024.e28468. eCollection 2024 Apr 15.
5
Association between basal metabolic rate and cardio-metabolic risk factors: Evidence from a Mendelian Randomization study.基础代谢率与心血管代谢危险因素之间的关联:一项孟德尔随机化研究的证据。
Heliyon. 2024 Mar 23;10(7):e28154. doi: 10.1016/j.heliyon.2024.e28154. eCollection 2024 Apr 15.
6
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.代谢相关脂肪性肝病:新命名对美国肝病研究学会非酒精性脂肪性肝病实践指南的影响及更新。
Hepatology. 2024 May 1;79(5):1212-1219. doi: 10.1097/HEP.0000000000000670. Epub 2023 Nov 9.
7
Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice.Cdo1-Camkk2-AMPK 轴赋予运动对 NAFLD 小鼠的保护作用。
Nat Commun. 2023 Dec 18;14(1):8391. doi: 10.1038/s41467-023-44242-7.
8
Causal association between basal metabolic rate and risk of cardiovascular diseases: a univariable and multivariable Mendelian randomization study.基础代谢率与心血管疾病风险之间的因果关系:单变量和多变量孟德尔随机化研究。
Sci Rep. 2023 Aug 1;13(1):12487. doi: 10.1038/s41598-023-39551-2.
9
The Influence of Sex Hormones in Liver Function and Disease.性激素对肝功能及疾病的影响。
Cells. 2023 Jun 11;12(12):1604. doi: 10.3390/cells12121604.
10
The etiopathogenesis and management of obesity: The quintessential quincunx.肥胖的病因和治疗:典型的五重奏。
J Pak Med Assoc. 2023 May;73(5):1134-1136. doi: 10.47391/JPMA.23-36.